Background: Central line-associated bloodstream infection (CLABSI) remains prevalent in hospitals in the United States.
W idespread patient safety efforts in the United
States have focused on health care-associated infection (HAI) (1, 2) . Common HAIs include central lineassociated bloodstream infection (CLABSI), catheterassociated urinary tract infection, Clostridioides difficile infection, and methicillin-resistant Staphylococcus aureus bloodstream infection. For many reasons, CLABSI is the prototypical HAI: It is common (3) and fatal and was once thought to be inevitable (4) . Even today, many people die of this preventable infection rather than the illness that brought them to the hospital (5) .
With the introduction of a checklist that systematically applied evidence to practice, rates of CLABSI in the United States declined 58% from 2001 to 2009 (3, 6) . However, success has not been uniform. Many hospitals continue to experience higher-than-expected CLABSI rates. These so-called low-performing hospitals may suffer from key problems, including demoralizing hospital culture (7, 8) , lack of auditing how CLABSI prevention bundles are implemented (9, 10) , failure to address patient-level risk factors (11, 12) , and increased use of central venous catheters in the non-intensive care unit setting (13, 14) . To date, no large-scale intervention to improve CLABSI rates in low-performing hospitals has been performed.
To identify and support hospitals struggling with CLABSI and other HAIs, the Centers for Disease Control and Prevention (CDC) funded a national project, STRIVE (States Targeting Reduction in Infections via Engagement) (15). This article reports findings from interventions aimed at reducing CLABSI. 12 months of postintervention data. The intervention began after sites completed a baseline assessment by using the Practice Change Assessment (PCA) or Infection Control Assessment and Response (ICAR) tool (16). The primary outcome was the number of CLABSIs per 1000 catheter-days for all hospitals and by hospital type (acute care, long-term acute care, and critical access). Cases of CLABSI were recorded through monthly data submitted to the National Healthcare Safety Network (NHSN) for participating hospitals. Secondary outcomes, also retrieved from NHSN, included central line utilization, which was calculated as the number of catheter-days per 100 patient-days.
Hospital characteristics, such as bed size, teaching status, ownership, hospital type, and location (urban, rural, or critical access), were obtained from the 2015 American Hospital Association Annual Survey of Hospitals (17) . "Critical access hospital" is a designation made by the Centers for Medicare & Medicaid Services and includes hospitals that are small (≤25 inpatient beds), have short lengths of stay (average ≤96 hours), and are located more than 35 miles from another hospital or serve a community that is otherwise physically remote from another hospital (for example, owing to terrain or road conditions). Responses to the ICAR or PCA were collected at baseline and at the end of the intervention. Baseline ICAR/PCA responses related to CLABSI prevention, line insertion, and line maintenance were evaluated to characterize hospital HAI prevention efforts before implementation.
Study Design and Cohort Recruitment
To recruit hospitals for STRIVE, the CDC used NHSN data to identify hospitals with high rates of HAI. High HAI burden was defined by the cumulative attributable difference (CAD) (calculated by using the Department of Health and Human Services' HAI goals as the standardized infection ratio target). On the basis of CAD values, facilities with a high burden of C difficile infection (above the first tertile, or top one third of hospitals) and elevated rates of CLABSI, catheterassociated urinary tract infection, or hospital-onset methicillin-resistant S aureus bloodstream infection were targeted for recruitment. This information was used to first identify states with the largest number of hospitals that had a high burden of HAI. Of the 30 states, including the District of Columbia, identified through this process, 24 agreed to participate. An additional 5 states that did not meet these criteria also volunteered to participate. All participating state hospital association leads were then given a list of potential target hospitals based on publicly reported NHSN infection rates to assist with hospital recruitment; however, any hospital within a participating state was allowed to join the STRIVE program regardless of HAI burden. A total of 462 hospitals (acute care, long-term acute care, and critical access) participated in STRIVE over 4 separate cohorts.
The STRIVE initiative included a multimodal evidencebased intervention for CLABSI that was designed and implemented across participating hospitals. Rates of CLABSI and central line utilization were collected. Cohort 1, the initial cohort, was designated a 10-month pilot to refine the identification and recruitment strategy. Each subsequent cohort was enrolled for 12 months. Cohort 1 began in June 2016, and cohort 4 ended in May 2018. This analysis includes data from the 387 hospitals that completed participation in cohorts 2 through 4, spanning 1 November 2016 to 31 May 2018.
The University of Michigan Medical School Institutional Review Board reviewed the study and determined that it did not meet the regulatory definition of research involving human subjects.
Intervention
To appeal to a broad range of health care facilities, STRIVE utilized a multimodal, multifaceted partneredfacilitation program (Appendix Figure 1 , available at Annals.org). The intervention consisted of 4 key components: a baseline assessment, a tiered approach to CLABSI prevention, online and on-demand educational materials, and guided facilitation for HAI reduction (15).
Baseline Assessment
After an overview and introduction to the project, a state partner (such as a state hospital association) performed an in-person assessment at each hospital by using either the ICAR (16) or the PCA. The PCA is a shorter version of the ICAR and was specifically developed for STRIVE. The PCA report generated from these tools included an executive summary that highlighted the hospital's 3 strongest practice areas and areas most in need of improvement. Project leads for the hospital used the summary generated from this report to communicate strategic goals with units and hospital leadership. Relevant STRIVE online resources were also identified to help sites in overcoming these barriers.
Tiered Approach
The STRIVE resources were organized into horizontal strategies for all HAIs and specific components for each HAI (for example, CLABSI, catheter-associated urinary tract infection) (18 -21) . The horizontal strategies included competency-based training, hand hygiene, use of personal protective equipment, environmental hygiene, antimicrobial stewardship, adaptive strategies, patient and family engagement, and a business case for infection prevention. The CLABSI-specific intervention included a tiered approach (18): Basic, fundamental CLABSI prevention interventions were emphasized in tier 1, whereas costlier and more labor-intensive approaches were introduced in tier 2. Before moving to tier 2, hospitals were asked to complete the CLABSI guide to patient safety, a self-check tool that helped identify key gaps in CLABSI prevention (22).
Educational Content and Strategies
The STRIVE team created 51 on-demand educational modules and made them available to participating hospitals through a central Web site. To guide implementation, the STRIVE project team also provided coaching, in-person meetings and site visits to hospitals, as needed. In addition, 31 monthly Learning Ac-
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tion Forum webinars were held to share best practices for infection prevention. The STRIVE team provided content expertise for these webinars and were available to answer questions from hospitals. Topics covered during the webinars were chosen to address challenges and barriers identified by the ICAR/PCA assessments, outcome data, state partner coaching activities, and specific topics requested by hospitals. To promote participant engagement, discussion, and peer-to-peer learning, webinars were conducted by using an interview or discussion format, rather than a didactic lecture (23) . Finally, 29 in-person meetings were also held, with every state involved with the project conducting at least one statewide meeting with their participating hospitals.
Site Visits
Site visits offered a way to provide on-site technical assistance to hospitals. During site visits, state leads reviewed hospital PCA reports and discussed outcome data, providing one-on-one coaching to hospitals usually through the hospital's infection prevention team. State hospital associations were expected to conduct site visits with at least 50% of their registered hospitals. Clinical mentors and subject-matter experts were also available if the state hospital associations requested assistance from the STRIVE project team.
Statistical Analysis
Hospital characteristics were reported by using descriptive statistics, including mean (SD), median (interquartile range), and number (percentage). Raw rates were calculated as the ratio of the total number of CLABSIs reported in each month (numerator) over the total number of catheter-days for that same month (denominator) multiplied by 1000. Raw aggregate CLABSI and central line utilization rates were tabulated monthly for the pre-and postintervention periods. Ninety-five percent CIs were calculated by using a bootstrap approach in which we resampled the data at each time point, recalculating the CLABSI incidence rate 10 000 times in each sample. A 95% normal-based CI was then calculated based on the bootstrap estimates. To display aggregated pre-and postintervention data by hospital, a Sankey bar graph was generated in SAS (SAS Institute) by using the macro %sankeybarchart (24) . All analyses were conducted in Stata, version 13 (Stata-Corp); SAS, version 9.4; and R Project (R Foundation for Statistical Computing).
Role of the Funding Source
The CDC funded the national STRIVE project team but had no role in the design of the study, writing of the article, or analysis of the data.
RESULTS
A total of 404 hospitals from 23 states (including the Midwest, South, Northwest, and West) and District of Columbia, were recruited as participants in STRIVE cohorts 2 through 4. Of these, 387 (95.8%) remained in the study for the 12-month intervention and 337 (83.4%) reported CLABSI outcome data (Appendix Figure 2 , avail-able at Annals.org). Characteristics of these hospitals are presented in Table 1 . The STRIVE initiative included both teaching and nonteaching sites (40.8% and 59.2%, respectively). Most (72.9%) hospitals were in an urban location, and 63.9% were nonprofit institutions. Most hospitals were acute care facilities (74.2%), whereas 10.1% were long-term acute care hospitals and 15.7% were critical access hospitals.
Of the 337 hospitals that reported outcome data, 334 (99.1%) submitted baseline ICAR/PCA data and 257 (76.3%) submitted follow-up data. Because the online educational modules were made open-access to facilitate participant engagement, intervention fidelity (such as the number of views or access by hospital) could not be measured. Responses to the baseline ICAR/PCA indicated that 71.0% (n = 237) of hospitals had a physician or nurse champion for CLABSI prevention activities. Approximately two thirds (67.1% [n = 224]) of hospitals reported that training was provided to personnel responsible for the insertion of central venous catheters, whereas 55.7% (n = 186) required personnel to demonstrate competency with insertion. Over 90% (90.4% [n = 302]) of hospitals required training for the maintenance of central venous catheters, whereas 64.7% (n = 216) required personnel to demonstrate competency with maintenance. Of all hospitals, 63.2% (n = 213) reported focusing on CLABSI reduction as a priority.
Outcomes
Monthly rates and 95% CIs for CLABSI and catheter utilization over the course of the project are shown in Appendix Figure 3 and Appendix Table 1 (available at Annals.org). In the preintervention period, there were 2855 cases of CLABSI, 3 245 535 catheter-days, and 13 493 193 In this Sankey bar chart, the connecting segments show how hospitals changed from the pre-to the postintervention periods. The slopes of the connecting segments should be interpreted cautiously because some segments connecting to the same rate category are increasing or decreasing visually but indicate no change in rates in these hospitals. Only segments that connect to a different category indicate changes in rates from the preto the postintervention period. CLABSI = central line-associated bloodstream infection.
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A total of 86 (25.9%) reporting hospitals had CLABSI rates of zero during both periods, whereas 50 (15.1%) hospitals achieved a 50% reduction in CLABSI in the postintervention period relative to the preintervention period (Appendix Table 2 , available at Annals .org). Among the hospitals that achieved a 50% reduction in CLABSI, 40 (80.0%) were acute care; 29 (63.0%) were nonteaching; 35 (76.1%) were urban; and 30 (65.2%) were nongovernment, nonprofit hospitals.
DISCUSSION
Despite a multimodal, multifaceted partneredfacilitation program built on education and evidencebased recommendations, this large-scale intervention did not result in substantial reduction of CLABSI rates across all participating hospitals. Key metrics related to vascular catheter use, such as device utilization ratio, also remained relatively stable and did not change in the postintervention period for most sites. Taken together, our findings suggest that a one-size-fits-all approach to preventing CLABSI in hospitals struggling with this infection may not be effective. Rather, novel and different approaches are needed to reduce CLABSI in these settings.
Nationally, CLABSI rates have trended down in recent years owing to collaborative efforts in patient safety (3, 25) . However, on close examination, much of the reduction in CLABSI comes from high-performing hospitals and from interventions in the intensive care unit setting (10, 25) . Selection bias often leads lowerperforming hospitals to drop out or opt out of large collaborative studies; hence, little is known about what works in low-performing sites (26) . Strategies that are successful in higher-performing hospitals (for example, education, guided implementation) may similarly not apply to lowerperforming hospitals (8) . Yet, to date, few have examined implementing what works in high-performing hospitals in low-performing ones. Although our findings suggest a negative study, by including diverse hospitals and settings that have less often been involved in large collaboratives focused on HAI prevention, valuable insights about these venues have been gleaned.
For instance, feedback from state partners indicated that a barrier to accessing online educational content was the need for a username and password. To facilitate engagement, online content was changed to open access, resulting in an inability to track engagement. Anecdotally, hospitals reported greater engagement with online materials after this change, but the STRIVE team received few requests for calls with subject-matter experts to facilitate learning or to understand how sites were using these materials at their hospitals. These insights tell us that no matter how easy it may be to make information available, this approach-by itself-may not be sufficient for low-performing hospitals.
What other lessons does this project provide? Although we cannot say with certainty why the intervention did not lead to a substantial reduction in CLABSI, several possibilities exist. First, competing priorities and weariness from tackling CLABSI may have contributed to lack of engagement (7, 27, 28). For example, the Matching Michigan study in the United Kingdom found that "CLABSI fatigue" led to the impression that efforts to reduce infection were redundant, unnecessary, or superfluous, thus limiting the intervention's impact (3, 7) . Of note, we observed significant improvement in device utilization in the preintervention data, a finding that suggests hospitals interested in preventing CLABSI began improvement efforts before the intervention formally began. It is possible, then, that by the time actual information was rolled out, this was perceived as redundant or unhelpful. Second, educational interventions tend to have limited effect, and the online approach used in STRIVE (including interactive modules and webinars that sites had to access) may have reduced impact (29, 30) . Third, without a clear incentive for sites to participate in state meetings or webinars or engage with online materials, the motivation to change may have waned. As noted earlier, we were unable to measure access rates, so it is possible that many hospitals and individuals associated with the study did not view the online evidence-based modules.
Our study has strengths. We targeted hospitals struggling with HAI prevention, a population rarely studied in the infection prevention literature. In addition, we expanded prior knowledge by including not only intensive care units but also general medicine/ surgical wards, rural hospitals, critical access hospitals, and long-term acute care facilities. Even though this was a negative study, we found that the usual "passive" approach to preventing HAIs (so often used by largescale interventions that include a combination of evidence, education, and guidance) may not work in hospitals struggling with CLABSI. Rather, a strategy that includes more active engagement may be necessary. Although we used an external facilitation approach (31), internal facilitation with hospitals with a "boots on the ground" approach may have been more helpful. Supportively, a facilitation strategy with external and internal components has been used successfully in the Veterans Affairs setting with sites that have struggled with implementation of a primary care model (32) .
Our study also has limitations. First, we did not have control sites or representative contemporary data to compare trends in infection rates. Thus, although we did not observe a substantial reduction in the preintervention versus the postintervention period, whether this occurred because sites were performing better than average at the outset cannot be assessed. Second, fidelity to the intervention could not be measured, limiting our ability to understand why sites improved or did not. Third, infection prevention programs at each hospital varied widely; differences in staffing, resources, and commitment to preventing CLABSI might explain some of our findings. Fourth, because our interventions targeted hospitals through a series of partners, we were unable to account for patient-level characteristics. Fifth, the intervention period was brief; it is possible that the full effect of interventions may not have been observed during the study period. Sixth, we did not measure organizational culture or attitudes. Finally, although sites with a high burden of HAI were targeted, overall rates of CLABSI were low, limiting the Results of a National CLABSI Intervention opportunities to improve CLABSI rates and central line utilization.
Limitations notwithstanding, our work has important policy implications. This project was intended to strengthen partnerships at the state level to improve infection prevention practices. Public policy has played a large role in CLABSI prevention. Financial penalties have been in place for hospitals with higher-thanexpected rates of CLABSI since 2008, and data are conflicting as to whether this has truly influenced safety or simply changed reporting (25, 33) . The additional pressure on hospitals related to financial penalties can lead to "gaming the system" and not reporting true infections (25) . Within the current system, therefore, some hospitals will always "lose." The efforts in STRIVE have at a minimum constructed a network of hospitals and state-level partnerships that can facilitate strengthening infection prevention in new ways. Future work that harnesses these partnerships-with a more intensive hands-on approach-may have important impact on clinical care and patient safety.
We believe that STRIVE has successfully raised HAI awareness, increased support for infection prevention activities, and optimized practices to improve patient safety in some sites (34) . National rates of HAI are trending downward, indicating that efforts in infection prevention are producing broad achievements for patients and providers (35) . Insight from STRIVE, particularly for hospitals struggling with higher rates of HAI, suggests that novel approaches including active engagement, strategies mindful of hospital culture, and a "carrot" rather than "stick" approach to incentivize improvement may be particularly important in lowperforming sites. Without these tailored approaches, hospitals struggling with persistently high CLABSI rates may never improve. 
